The microbiota as a modulator of mucosal inflammation and HIV/HPV pathogenesis: From association to causation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 17 10 2022
accepted: 06 01 2023
entrez: 9 2 2023
pubmed: 10 2 2023
medline: 11 2 2023
Statut: epublish

Résumé

Although the microbiota has largely been associated with the pathogenesis of viral infections, most studies using omics techniques are correlational and hypothesis-generating. The mechanisms affecting the immune responses to viral infections are still being fully understood. Here we focus on the two most important sexually transmitted persistent viruses, HPV and HIV. Sophisticated omics techniques are boosting our ability to understand microbiota-pathogen-host interactions from a functional perspective by surveying the host and bacterial protein and metabolite production using systems biology approaches. However, while these strategies have allowed describing interaction networks to identify potential novel microbiota-associated biomarkers or therapeutic targets to prevent or treat infectious diseases, the analyses are typically based on highly dimensional datasets -thousands of features in small cohorts of patients-. As a result, we are far from getting to their clinical use. Here we provide a broad overview of how the microbiota influences the immune responses to HIV and HPV disease. Furthermore, we highlight experimental approaches to understand better the microbiota-host-virus interactions that might increase our potential to identify biomarkers and therapeutic agents with clinical applications.

Identifiants

pubmed: 36756132
doi: 10.3389/fimmu.2023.1072655
pmc: PMC9900135
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1072655

Informations de copyright

Copyright © 2023 Moreno, Ron and Serrano-Villar.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
Cancer Res. 2004 Feb 15;64(4):1359-68
pubmed: 14973079
Sci Data. 2019 Feb 19;6:190021
pubmed: 30778255
Curr Opin HIV AIDS. 2008 May;3(3):356-61
pubmed: 19372990
J Virol. 2008 Jan;82(1):538-45
pubmed: 17959677
Pathog Immun. 2020 Dec 30;5(1):364-381
pubmed: 33501400
J Clin Microbiol. 2013 Jul;51(7):2182-94
pubmed: 23637301
AIDS. 2015 Jan 2;29(1):43-51
pubmed: 25387317
Cell Host Microbe. 2019 Aug 14;26(2):273-282.e7
pubmed: 31378678
J Int AIDS Soc. 2019 May;22(5):e25300
pubmed: 31144462
Sex Transm Dis. 2003 Mar;30(3):257-61
pubmed: 12616147
Int J Mol Sci. 2019 Jan 11;20(2):
pubmed: 30641869
Microbiome. 2019 May 11;7(1):73
pubmed: 31078141
Carcinogenesis. 2010 Nov;31(11):1905-12
pubmed: 20819779
J Infect Dis. 2015 Aug 15;212(4):578-84
pubmed: 25701868
Microbiome. 2021 Mar 29;9(1):79
pubmed: 33781324
AIDS. 2017 Feb 20;31(4):591-594
pubmed: 27922858
Biomedicines. 2020 Apr 08;8(4):
pubmed: 32276347
Nat Med. 2022 Apr;28(4):690-703
pubmed: 35440726
BMC Womens Health. 2019 Jul 24;19(1):103
pubmed: 31340789
Mucosal Immunol. 2017 Sep;10(5):1310-1319
pubmed: 28120845
J Infect Dis. 2014 Oct 15;210(8):1248-59
pubmed: 24795473
Clin Dev Immunol. 2012;2012:935425
pubmed: 22400042
Oncol Lett. 2015 Mar;9(3):1015-1026
pubmed: 25663851
AMB Express. 2020 Mar 12;10(1):46
pubmed: 32166638
Mucosal Immunol. 2020 Sep;13(5):753-766
pubmed: 32152415
J Pharm Biomed Anal. 2020 Jan 5;177:112867
pubmed: 31614303
Clin Cancer Res. 2017 Jan 15;23(2):370-378
pubmed: 27440266
Semin Cancer Biol. 2022 Nov;86(Pt 3):189-198
pubmed: 35276341
Trends Microbiol. 2011 Jul;19(7):349-59
pubmed: 21684749
Int J Nanomedicine. 2017 Sep 12;12:6813-6825
pubmed: 28979120
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):256-63
pubmed: 25469528
Sci Rep. 2019 May 14;9(1):7333
pubmed: 31089160
Sci Rep. 2016 May 18;6:26192
pubmed: 27189771
Front Cell Infect Microbiol. 2020 Aug 11;10:341
pubmed: 32850467
Microbiome. 2013 Oct 12;1(1):26
pubmed: 24451087
Nat Commun. 2022 Feb 28;13(1):1076
pubmed: 35228537
AIDS. 2018 Jul 31;32(12):1589-1598
pubmed: 29620717
Curr Probl Cancer. 2022 Aug;46(4):100877
pubmed: 35709613
Annu Rev Immunol. 2012;30:149-73
pubmed: 22224779
Crit Rev Microbiol. 2018 Aug;44(4):465-486
pubmed: 29345518
J Infect Dis. 2015 Jan 1;211(1):19-27
pubmed: 25057045
Semin Liver Dis. 1992 May;12(2):167-74
pubmed: 1636119
Biomed Pharmacother. 2020 Jul;127:110203
pubmed: 32559847
AIDS. 2018 Jun 19;32(10):1229-1237
pubmed: 29683848
ISME J. 2018 Aug;12(8):1964-1976
pubmed: 29789624
Nat Commun. 2019 Dec 11;10(1):5656
pubmed: 31827089
Clin Infect Dis. 2019 Jan 1;68(1):120-130
pubmed: 29788075
Anal Chim Acta. 2018 Nov 7;1030:1-24
pubmed: 30032758
Clin Biochem. 2011 Jun;44(8-9):596-600
pubmed: 21349258
Microbes Infect. 2006 Aug;8(9-10):2469-76
pubmed: 16914350
Curr Opin HIV AIDS. 2018 Jan;13(1):88-94
pubmed: 29035945
Sci Transl Med. 2013 Jul 10;5(193):193ra91
pubmed: 23843452
Expert Rev Proteomics. 2019 Jun;16(6):501-511
pubmed: 30223687
Cell. 2022 Apr 14;185(8):1356-1372.e26
pubmed: 35395179
Cell. 2006 Sep 8;126(5):847-50
pubmed: 16959564
Curr Opin Microbiol. 2018 Aug;44:50-60
pubmed: 30056329
PLoS Pathog. 2009 Feb;5(2):e1000318
pubmed: 19247434
PLoS One. 2011;6(8):e23442
pubmed: 21858117
J Clin Invest. 2016 May 2;126(5):1630-9
pubmed: 27135880
Microbiome. 2021 Dec 10;9(1):239
pubmed: 34893070
AIDS. 2016 Nov 28;30(18):2737-2751
pubmed: 27755100
Cancer Lett. 2013 Feb 28;329(2):137-45
pubmed: 23142293
PLoS Pathog. 2014 Feb 20;10(2):e1003829
pubmed: 24586144
EBioMedicine. 2016 Jun;8:203-216
pubmed: 27428431
Cell Host Microbe. 2013 Sep 11;14(3):329-39
pubmed: 24034618
Nat Methods. 2019 Dec;16(12):1306-1314
pubmed: 31686038
Curr HIV Res. 2011 Dec 1;9(8):630-5
pubmed: 22211657
J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):329-37
pubmed: 26258571
PLoS One. 2016 May 12;11(5):e0155100
pubmed: 27171281
BMC Infect Dis. 2017 Jun 23;17(1):445
pubmed: 28645263
BMC Womens Health. 2019 Aug 12;19(1):109
pubmed: 31405377
NPJ Biofilms Microbiomes. 2021 Dec 13;7(1):88
pubmed: 34903740
Nat Rev Microbiol. 2018 Jun 24;16:540-550
pubmed: 29937540
Virus Res. 2020 Aug;285:198018
pubmed: 32430279
J Turk Ger Gynecol Assoc. 2019 Sep 30;21(3):193-200
pubmed: 31564082
BJOG. 2020 Jan;127(2):182-192
pubmed: 31749298
PLoS One. 2008 Jun 25;3(6):e2516
pubmed: 18575590
Int J Mol Sci. 2022 Jun 28;23(13):
pubmed: 35806188
Front Microbiol. 2017 May 19;8:906
pubmed: 28579980
J Exp Med. 2004 Sep 20;200(6):749-59
pubmed: 15365096
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12115-20
pubmed: 16880384
Mucosal Immunol. 2015 Sep;8(5):1009-20
pubmed: 25586559
Front Immunol. 2016 Dec 19;7:614
pubmed: 28066424
Clin Microbiol Infect. 2019 Jan;25(1):35-47
pubmed: 29729331
PLoS Pathog. 2021 May 13;17(5):e1009508
pubmed: 33984071
Biochem Biophys Res Commun. 2016 Jan 22;469(4):967-77
pubmed: 26718401
Sci Rep. 2018 Sep 24;8(1):14277
pubmed: 30250162
NPJ Precis Oncol. 2020 Aug 3;4:22
pubmed: 32802959
J Exp Med. 1997 Mar 3;185(5):805-16
pubmed: 9120386
Gut Microbes. 2021 Jan-Dec;13(1):1997292
pubmed: 34818131
BMJ. 2018 Jun 13;361:k2179
pubmed: 29899036
Clin Infect Dis. 2015 Jul 15;61(2):260-9
pubmed: 25900168
Mucosal Immunol. 2015 Jul;8(4):760-72
pubmed: 25407519
Med Klin (Munich). 1992 Oct 15;87(10):510-2, 549
pubmed: 1361023
BJOG. 2020 Jan;127(2):171-180
pubmed: 31237400
PLoS Pathog. 2016 Dec 7;12(12):e1006048
pubmed: 27926931
Sci Rep. 2018 May 15;8(1):7593
pubmed: 29765068
Cell Host Microbe. 2014 Jan 15;15(1):36-46
pubmed: 24439896
PLoS Pathog. 2020 Jun 4;16(6):e1008524
pubmed: 32497113
Gut Microbes. 2017 Sep 3;8(5):440-450
pubmed: 28541799
Arch Microbiol. 2022 Jul 16;204(8):491
pubmed: 35840844
Immunol Cell Biol. 2021 Feb;99(2):168-176
pubmed: 32924178
Nature. 2008 May 29;453(7195):620-5
pubmed: 18509436
PLoS Pathog. 2019 Apr 4;15(4):e1007611
pubmed: 30947289
Immunology. 2014 May;142(1):24-31
pubmed: 24329495
EBioMedicine. 2018 Apr;30:192-202
pubmed: 29650491
Nat Rev Genet. 2017 Nov;18(11):690-699
pubmed: 28824167
J Virol. 2003 Nov;77(21):11708-17
pubmed: 14557656
Genome Res. 2014 Feb;24(2):185-99
pubmed: 24201445
Nat Commun. 2021 Feb 18;12(1):1139
pubmed: 33602945
Microbiome. 2020 Nov 21;8(1):165
pubmed: 33220709
Blood. 2000 Oct 15;96(8):2649-54
pubmed: 11023494
J Infect Dis. 2014 Oct 15;210(8):1228-38
pubmed: 24755434
Nature. 2020 Nov;587(7834):448-454
pubmed: 33149306
Mucosal Immunol. 2011 Sep;4(5):554-63
pubmed: 21525866
Curr Opin HIV AIDS. 2016 Mar;11(2):182-90
pubmed: 26679414
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Sci Rep. 2019 Nov 18;9(1):16965
pubmed: 31740720
J Virol. 2007 Jan;81(2):599-612
pubmed: 17065209
Annu Rev Genet. 2017 Nov 27;51:413-433
pubmed: 28934590
Cell. 2022 Jul 21;185(15):2725-2738
pubmed: 35868276
J Virol. 2021 Aug 25;95(18):e0047921
pubmed: 34232744
J Periodontol. 1991 Jan;62(1):74-81
pubmed: 2002434
Cancer Prev Res (Phila). 2016 May;9(5):357-66
pubmed: 26935422
Mucosal Immunol. 2017 Sep;10(5):1279-1293
pubmed: 28000678
Sci Rep. 2018 Jun 11;8(1):8812
pubmed: 29891956
J Infect Dis. 2021 Feb 13;223(3):471-481
pubmed: 32601702
J Infect Dis. 2015 Mar 1;211(5):780-90
pubmed: 25214516
Cancers (Basel). 2019 Sep 06;11(9):
pubmed: 31500086
Clin Microbiol Rev. 2010 Oct;23(4):837-57
pubmed: 20930075
Open Forum Infect Dis. 2021 Dec 07;8(12):ofab550
pubmed: 34888397
Front Cell Infect Microbiol. 2021 Aug 05;11:649940
pubmed: 34422675
PLoS One. 2016 Apr 26;11(4):e0153274
pubmed: 27115350
Front Microbiol. 2020 Aug 18;11:1925
pubmed: 33013732
Sci Rep. 2017 Aug 29;7(1):9802
pubmed: 28852043
mSystems. 2022 Apr 26;7(2):e0006422
pubmed: 35343798
J Infect Dis. 2019 Jan 9;219(3):497-508
pubmed: 30202890
Nat Rev Genet. 2020 Jun;21(6):339-354
pubmed: 32060427
Clin Infect Dis. 2013 Jul;57(1):139-46
pubmed: 23511299
J Med Virol. 2022 Sep;94(9):4478-4484
pubmed: 35527233
Curr HIV/AIDS Rep. 2020 Aug;17(4):394-404
pubmed: 32535769
Cell Host Microbe. 2017 Apr 12;21(4):530-537.e4
pubmed: 28366509
Br J Cancer. 2006 Dec 4;95(11):1555-61
pubmed: 17117179
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1954-9
pubmed: 20647411
Minerva Obstet Gynecol. 2021 Oct;73(5):621-631
pubmed: 33876901
mSystems. 2021 Aug 31;6(4):e0077321
pubmed: 34427533
Mucosal Immunol. 2014 Jul;7(4):983-94
pubmed: 24399150
Pathog Immun. 2019 Sep 23;4(2):235-250
pubmed: 31583331
Nat Microbiol. 2021 Dec;6(12):1483-1492
pubmed: 34819645
Open Forum Infect Dis. 2019 Dec 03;7(1):ofz507
pubmed: 31950071
Proc Natl Acad Sci U S A. 2022 May 3;119(18):e2118483119
pubmed: 35476531
Front Immunol. 2019 Jun 27;10:1466
pubmed: 31316514
Front Immunol. 2021 Sep 20;12:676669
pubmed: 34616391
EBioMedicine. 2019 Jun;44:675-690
pubmed: 31027917
Nat Rev Dis Primers. 2016 Dec 01;2:16086
pubmed: 27905473
Cell. 2021 Jul 22;184(15):3899-3914.e16
pubmed: 34237254
PLoS Pathog. 2020 Mar 26;16(3):e1008376
pubmed: 32214382
Hum Immunol. 2012 Sep;73(9):920-6
pubmed: 22749886
Metabolites. 2020 Jan 15;10(1):
pubmed: 31952112
Immunity. 2013 Oct 17;39(4):633-45
pubmed: 24138880
Microbiome. 2016 Nov 1;4(1):58
pubmed: 27802830
Gut. 2009 Feb;58(2):220-7
pubmed: 18936106
J Leukoc Biol. 2019 Apr;105(4):783-795
pubmed: 30776150
iScience. 2020 Aug 21;23(8):101414
pubmed: 32777774
J Immunol Res. 2018 Dec 13;2018:3734207
pubmed: 30648120
PLoS One. 2014 Jul 10;9(7):e102215
pubmed: 25010422
AIDS. 2013 Jul 31;27(12):1921-31
pubmed: 24180001
Front Cell Infect Microbiol. 2020 Sep 25;10:569022
pubmed: 33102255
Cell. 2020 Jan 23;180(2):221-232
pubmed: 31978342
J Biol Chem. 2015 Jan 9;290(2):1020-38
pubmed: 25406321
Nat Rev Immunol. 2015 Jun;15(6):375-87
pubmed: 25976515

Auteurs

Elena Moreno (E)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.
CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.

Raquel Ron (R)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.
CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.

Sergio Serrano-Villar (S)

Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.
CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH